SR ONE CAPITAL MANAGEMENT, LP

Holdings History for ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Symbol: SPRY on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	6.6%	0%	$46,750,320	4,012,903	0		$11.65	Q4 2025
30 Sep 2025	5.8%	0%	$40,329,675	4,012,903	0		$10.05	Q3 2025
30 Jun 2025	15%	0%	$70,025,157	4,012,903	0		$17.45	Q2 2025
31 Mar 2025	13%	0%	$50,482,320	4,012,903	0		$12.58	Q1 2025
31 Dec 2024	10%	0%	$42,336,127	4,012,903	0		$10.55	Q4 2024
30 Sep 2024	12%	0%	$58,187,094	4,012,903	0		$14.50	Q3 2024
30 Jun 2024	11%	0%	$34,149,805	4,012,903	0		$8.51	Q2 2024
31 Mar 2024	11%	0%	$41,011,869	4,012,903	0		$10.22	Q1 2024
31 Dec 2023	9.2%	0%	$21,990,708	4,012,903	0		$5.48	Q4 2023
30 Sep 2023	7.8%	0%	$15,168,773	4,012,903	0		$3.78	Q3 2023
30 Jun 2023	12%	0%	$26,886,450	4,012,903	0		$6.70	Q2 2023
31 Mar 2023	9.7%	+2.4%	$26,123,999	4,012,903	+1,003,226	+33%	$6.51	Q1 2023
31 Dec 2022	9.4%	+9.4%	$25,672,544	3,009,677	+3,009,677	NEW	$8.53	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.